L. Burns

发表

Translation of Clinical Research into Practice: An Impact Assessment of the Results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization.

M. Horowitz, Stephanie J. Lee, N. Khera, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post‐transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

K. Syrjala, B. Shaw, R. Phelan, 2018, Cancer.

Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.

J. Steinberger, K. Ness, C. Sklar, 2005, Blood.

Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.

M. Pasquini, M. Horowitz, Stephanie J. Lee, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic natural killer cells for refractory lymphoma

B. Lindgren, Jeffrey S. Miller, D. Weisdorf, 2010, Cancer Immunology, Immunotherapy.

M. Aljurf, J. Szer, J. Wingard, 2012, Bone Marrow Transplantation.

J. Wingard, A. Tichelli, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006, Blood.

Utilization of Chimeric Antigen Receptor (CAR) T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B cell non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

M. Bar, F. Awan, D. Miklos, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

C. Le, J. Wagner, Jeffrey S. Miller, 2005, Blood.

Iron overload in hematopoietic cell transplantation

H. Lazarus, N. Majhail, L. Burns, 2008, Bone Marrow Transplantation.

Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high‐risk myelodysplastic syndromes: Challenges and opportunities in implementation

D. Steensma, Bryce Waldman, A. Brunner, 2021, Cancer.

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

D. Kaufman, J. Wagner, K. Dusenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma

L. Burns, R. Lerner, L. J. Burns, 2003, Bone Marrow Transplantation.

Effects of smoking on outcomes of hematopoietic cell transplantation: a systemic review and future directions

S. Ehlers, S. Hashmi, L. Burns, 2019, Bone Marrow Transplantation.

Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplant Survivors: An Initial Survey.

W. Wood, Stephanie J. Lee, K. Syrjala, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Burnout, Moral Distress, Work-Life Balance, and Career Satisfaction among Hematopoietic Cell Transplantation Professionals.

W. Wood, T. Shanafelt, M. Perales, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation.

D. Weisdorf, V. Bachanova, L. Burns, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma

D. Weisdorf, V. Bachanova, J. Miller, 2009, Bone Marrow Transplantation.

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

Jeffrey S. Miller, D. Weisdorf, A. Panoskaltsis-Mortari, 2018, Cancer Immunology, Immunotherapy.

Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.

Sonali M. Smith, M. Norkin, D. Maloney, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

haploidentical NK cells in cancer patients Successful adoptive transfer and in vivo expansion of human

Jeffrey S. Miller, D. Weisdorf, A. Panoskaltsis-Mortari, 2012 .

Guideline Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma : Guidelines from the American Society for Blood and Marrow Transplantation

J. Vose, M. Perales, A. Evens, 2015 .

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

J. Vose, M. Perales, A. Evens, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.

D. Weisdorf, V. Bachanova, L. Burns, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms

D. Kleiner, S. Bhatia, E. Engels, 2017 .

M. Aljurf, J. Szer, J. Wingard, 2012, Revista brasileira de hematologia e hemoterapia.

A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.

H. Lazarus, N. Majhail, L. Burns, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.

H. Lazarus, T. DeFor, N. Majhail, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.

M. Pasquini, Stephanie J. Lee, B. Shaw, 2022, Transplantation and cellular therapy.

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin.

M. Willingham, A. Frankel, J. Kersey, 1997, Leukemia & lymphoma.

Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody.

M. Brechbiel, J. Wagner, K. Dusenbery, 2004, Cancer biotherapy & radiopharmaceuticals.

Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a 90Y-Labeled Anti-CD22 Monoclonal Antibody

M. Brechbiel, A. Panoskaltsis-Mortari, D. Vallera, 2005, Clinical Cancer Research.

CLONAL HEMATOPOIESIS IN RELATED ALLOGENEIC TRANSPLANT DONORS: IMPLICATIONS FOR SCREENING AND MANAGEMENT.

B. Shaw, G. Switzer, B. Logan, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous and Allogeneic Hematopoieitic Cell Transplantation: Risk of Second Malignancies

L. Burns, B. Trottier, 2014 .

Role of allogeneic stem cell transplantation in mantle cell lymphoma

V. Bachanova, L. Burns, Jonathon B. Cohen, 2015, European journal of haematology.

A novel four-drug ablative regimen with hemopoietic stem cell rescue for patients with breast cancer: a phase II study.

R. Hohl, R. Gingrich, L. Burns, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report.

M. Aljurf, G. Basak, N. Chaudhri, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation.

D. Mulrooney, M. Arora, A. Blaes, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins.

G. Vercellotti, L. Burns, M. L. Weber, 1999, Transplantation.

Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.

G. Vercellotti, H. Jacob, L. Burns, 1996, The American journal of pathology.

Subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology.

S. Gitlin, R. Todd, L. Burns, 2004, Blood.

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.

D. Weisdorf, J. Miller, T. Repka, 2000, Experimental hematology.

What do transplant physicians think about palliative care? A national survey study

W. Wood, A. El-Jawahri, T. Leblanc, 2017, Cancer.

A new standard in GVHD prophylaxis? An introduction to BMT CTN 1703.

W. Wood, Bryce Waldman, Z. DeFilipp, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

J. Pidala, Stephanie J. Lee, M. Flowers, 2016 .

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Addressing Knowledge Gaps in Acute Myeloid Leukemia to Improve Referral for Hematopoietic Cell Transplantation Consultation.

L. Mau, E. Denzen, Christa L. Meyer, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Extrapyramidal symptoms in a BMT recipient with hyperintense basal ganglia and elevated manganese.

S. Fredstrom, L. Burns, J. Rogosheske, 1995, Bone marrow transplantation.

Vitamin D status among long-term survivors of hematopoietic cell transplantation

D. Mulrooney, K. Robien, D. Lazovich, 2010, Bone Marrow Transplantation.

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

M. Perales, J. Pidala, B. Shaw, 2019, Blood.

Comparison of Characteristics and Outcomes of Trial Participants and Non-participants: Example of Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

W. Wood, M. Aljurf, J. Wingard, 2015 .

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European S

M. Aljurf, R. Gale, N. Callander, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

M. Aljurf, R. Gale, N. Callander, 2019, Bone Marrow Transplantation.

Only the HLA class I gene minimal promoter elements are required for transactivation by human cytomegalovirus immediate early genes

J. Waring, M. Stinski, L. Burns, 1993 .

Only the HLA class I gene minimal promoter elements are required for transactivation by human cytomegalovirus immediate early genes.

J. Waring, M. Stinski, L. Burns, 1993, Blood.

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.

S. Montoto, Sonali M. Smith, P. Hari, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radioimmunotherapy of CD 22-Expressing Daudi Tumors in Nude Micewith a 90 Y-Labeled Anti-CD 22 Monoclonal Antibody

M. Brechbiel, D. Vallera, E. Vitetta, 2005 .

Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.

M. Brechbiel, J. Wagner, K. Dusenbery, 2003, Cancer biotherapy & radiopharmaceuticals.

Successful Remission Rates and Survival after Lymphodepleting Chemotherapy for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2014 .

Transplantation Using Bone Marrow from a (very) HLA Mismatched Unrelated Donor in the Setting of Post-Transplant Cyclophosphamide Is Feasible and Expands Access to Underserved Minorities

M. Norkin, M. Perales, M. Horowitz, 2020 .

Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction

M. Patnaik, M. Pritzker, M. Bunte, 2008, Bone Marrow Transplantation.

Pulmonary Venoocclusive Disease Following Hematopoietic Stem Cell Transplantation

M. Bunte, L. Burns, 2011 .

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

J. Vose, M. Aljurf, R. Gale, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Solid organ transplantation in survivors of hematopoietic cell transplantation: a single institution case series and literature review

N. Majhail, L. Burns, A. Beitinjaneh, 2010, Clinical transplantation.

Current Status of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation in AML Management 9

E. Shpall, A. Barrett, K. Ballen, 2010 .

Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia

P. Gupta, D. Weisdorf, B. Jahagirdar, 2008, American journal of hematology.

Transplantation provides superior survival high risk myeloid malignancies in older patients

C. Ustun, L. Burns, E. Warlick, 2022, Leukemia & lymphoma.

preparative regimen for advanced Hodgkin lymphoma donor hematopoietic stem cell transplantation after reduced-intensity Comparable results of umbilical cord blood and HLA-matched sibling

J. Wagner, D. Weisdorf, T. DeFor, 2013 .

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma.

J. Wagner, D. Weisdorf, T. DeFor, 2006, Blood.

Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.

R. Parkkola, P. Armand, M. Itälä-Remes, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

S. Montoto, Sonali M. Smith, P. Hari, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT

V. Bachanova, J. Froelich, C. Ustun, 2015, Bone Marrow Transplantation.

Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings.

A. D’Souza, W. Saber, L. Mau, 2020, Biology of Blood and Marrow Transplantation.

Biobehavioral research and hematopoietic stem cell transplantation: Expert review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy.

W. Wood, H. Jim, K. Syrjala, 2021, Transplantation and cellular therapy.

Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023

C. Bollard, M. Horowitz, J. Wingard, 2020, Biology of Blood and Marrow Transplantation.

A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703

W. Wood, Bryce Waldman, Z. DeFilipp, 2020 .

Title : " Risk Score for Veno-occlusive Disease After Allogeneic Stem-Cell Transplant "

Marcelo, M. Horowitz, Stephanie J. Lee, 2017 .

Randomized Phase III Trial of 131iodine-Tositumomab (Bexxar)/Carmustine, Etoposide, Cytarabine, Melphalan (BEAM) Vs. Rituximab/BEAM and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL): No Difference in Progression-Free (PFS) or Overall Survival (OS)

J. Vose, S. Mineishi, M. Horowitz, 2011 .

BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma.

R. Gingrich, L. Burns, G. Ginder, 1990, Blood.

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

D. Kaufman, J. Wagner, K. Dusenbery, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field.

A. Bracey, E. Nemecek, M. Pulsipher, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.

M. Perales, M. Litzow, N. Majhail, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Feasibility of Centralized Electronic Patient-Reported Outcome (ePRO) Collection By an Outcome Registry, a CIBMTR Study of Patients on the Centers for Medicaid & Medicare Coverage with Evidence Development (CMS CED) Myelodysplasia Protocol

M. Horowitz, J. Pidala, Stephanie J. Lee, 2020 .

Autologous (auto) Versus Allogeneic (allo) Hematopoietic Cell Transplantation (HCT) for T-NHL: A CIBMTR Analysis

S. Montoto, Sonali M. Smith, P. Hari, 2010 .

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

C. Verfaillie, J. Lebkowski, D. Weisdorf, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Iron-overload after autologous hematopoietic cell transplantation.

H. Lazarus, T. DeFor, N. Majhail, 2009, Leukemia research.

PHYSICIAN PERCEPTIONS AND PRACTICE PATTERNS REGARDING FERTILITY PRESERVATION IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

M. Sorror, J. Wingard, J. Pidala, 2013, Bone Marrow Transplantation.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.

M. Perales, A. Nagler, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

M. Aljurf, J. Szer, J. Wingard, 2012, Biology of Blood and Marrow Transplantation.

Chronic graft-versus-host disease: a prospective cohort study.

M. MacMillan, S. Davies, D. Weisdorf, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Disseminated Fusarium infections in patients following bone marrow transplantation.

R. Gingrich, M. Pfaller, L. Burns, 1989, Bone marrow transplantation.

New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.

L. Robison, J. Neglia, T. DeFor, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

A. Barrett, D. Kleiner, S. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.

C. Cutler, B. Hamilton, N. Khera, 2022, Transplantation and cellular therapy.

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

R. Advani, A. Nademanee, J. Friedberg, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial

D. Vesole, D. Weisdorf, B. Blazar, 2003, Bone Marrow Transplantation.

Transcriptional activation of an embryonic globin gene in adult erythroid cells in vivo.

M. Whitters, L. Burns, J. Pohlman, 1985, Progress in clinical and biological research.

Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies.

A. Frankel, J. Kersey, D. Vallera, 1996, Journal of immunological methods.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Butyrate induces selective transcriptional activation of a hypomethylated embryonic globin gene in adult erythroid cells.

L. Burns, J. Glauber, G. Ginder, 1988, Blood.

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.

J. Vose, P. Hari, R. Gale, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients

D. Mulrooney, L. Burmeister, A. Blaes, 2011, Bone Marrow Transplantation.

M. Aljurf, J. Szer, J. Wingard, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease resulting from normal donor blood transfusions.

L. Klassen, C. Burns, L. Burns, 1984, Acta haematologica.

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

Avis J. Thomas, D. Kaufman, J. Wagner, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease and Search Prognosis.

B. Shaw, S. Spellman, S. Devine, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

Jeffrey S. Miller, J. Miller, T. Repka, 1999, Experimental hematology.

The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.

D. Weisdorf, W. Thomas, T. DeFor, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.

J. Wingard, S. Spellman, G. Switzer, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplant cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial.

M. Norkin, M. Perales, J. Pidala, 2022, Transplantation and cellular therapy.

Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR.

S. Montoto, P. Hari, R. Gale, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

M. Norkin, M. Perales, M. Horowitz, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia

D. Vanness, W. Saber, L. Mau, 2019, JNCI cancer spectrum.

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved Overall Survival of Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Following 7/8 HLA-Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of the Center for International Blood and Marrow Transplant Research Database

M. Pasquini, Michael T. Hemmer, L. Kean, 2021, Blood.

Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Bone Marrow: A Prespecified Analysis from the Phase III BMT CTN Protocol 0201

J. Wingard, S. Spellman, G. Switzer, 2016 .

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.

Jeffrey S. Miller, D. Weisdorf, M. Arora, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

J. Wagner, Priya Kumar, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors

Purushottam W. Laud, J. Wingard, K. Syrjala, 2018, Haematologica.

Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.

K. Ness, S. Bhatia, S. Forman, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.

Alan M. Miller, J. Armitage, J. Vose, 2003, Blood.

Determinants of survival after human leucocyte antigen‐matched unrelated donor bone marrow transplantation in adults

Jeffrey S. Miller, S. Davies, D. Weisdorf, 2002, British Journal of Haematology.

J. Wingard, A. Tichelli, S. Davies, 2006, Bone Marrow Transplantation.

Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Annals of the American Thoracic Society.

Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

M. Perales, J. Pidala, B. Shaw, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Ruta Bajorunaite, Arturo Molina, John Gibson, 2003, Blood.

Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.

D. Kadidlo, D. McKenna, J. McCullough, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

Alan M. Miller, J. Vose, Sonali M. Smith, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma

J. Wagner, D. Weisdorf, J. Miller, 2007, Bone Marrow Transplantation.

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

C. Le, K. Dusenbery, Jeffrey S. Miller, 2006 .

Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation

J. Wagner, C. Verfaillie, K. Dusenbery, 2000, Bone Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies

K. Lindblad-Toh, J. Modiano, D. Ito, 2017, Leukemia & lymphoma.

Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.

Avis J. Thomas, D. Kaufman, J. Wagner, 2007 .

Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach

D. Vanness, N. Majhail, W. Saber, 2020, PharmacoEconomics.

Patient-centered care coordination in hematopoietic cell transplantation.

N. Majhail, N. Khera, C. Lemaistre, 2017, Blood advances.

Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.

D. Vanness, N. Majhail, W. Saber, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum.

A. Krishnan, W. Wood, M. Perales, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial.

J. Vose, R. Fisher, M. Horowitz, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.

D. Mulrooney, N. Majhail, K. Baker, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Human Leukocyte Antigen A2 Interferon-stimulated Response Element Consensus Sequence Binds a Nuclear Factor Required for Constitutive Expression (*)

J. Waring, L. Burns, J. Radford, 1995, The Journal of Biological Chemistry.

New M alignancies A fter B lood o r M arrow S tem-Cell Transplantation i n C hildren a nd A dults: Incidence a nd R isk F actors

L. Robison, J. Neglia, T. DeFor, 2003 .

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation.

W. Wood, M. Horowitz, K. Syrjala, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.

Jeffrey S. Miller, E. Chiorean, D. Weisdorf, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

J. Liesveld, Z. DeFilipp, B. Shaw, 2020, Blood advances.

A Conceptual Framework and Key Research Questions in Educational Needs of Blood and Marrow Transplantation Patients, Caregivers, and Families.

M. Bevans, B. Shaw, H. Schoemans, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients.

D. Weisdorf, T. DeFor, L. Burns, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.

J. Wingard, K. Syrjala, N. Majhail, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Molecular Regulation of Immune Recognition Molecule Expression by Breast Cancer Cells

L. Burns, 1999 .

Administrative Claims Data for Economic Analyses in Hematopoietic Cell Transplantation: Challenges and Opportunities.

D. Vanness, N. Majhail, W. Saber, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New Classification of Chronic Graft Versus Host Disease: Added Clarity from the Consensus Diagnoses.

M. MacMillan, D. Weisdorf, M. Arora, 2007 .

Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality.

D. Niederwieser, M. Litzow, S. Schwind, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

K. Ness, M. Flowers, M. Arora, 2009, Bone Marrow Transplantation.

Why Waldenström macroglobulinemia is not just another indolent lymphoma

V. Bachanova, R. Cornell, L. Burns, 2014 .

Hematopoietic cell transplantation for Waldenström macroglobulinemia

V. Bachanova, L. Burns, L. J. Burns, 2012, Bone Marrow Transplantation.

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial

J. Wagner, D. Douek, M. MacMillan, 2007, Bone Marrow Transplantation.

Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.

T. DeFor, N. Majhail, S. Cooley, 2013, Blood.

measured liver iron content − transplantation outcomes : a prospective cohort study using R 2-MRI Association of iron overload with allogeneic hematopoietic cell

T. DeFor, N. Majhail, S. Cooley, 2013 .

Engaging hematopoietic cell transplantation patients and caregivers in the design of print and mobile application individualized survivorship care plan tools

K. Syrjala, Jean C. Yi, N. Majhail, 2019, Supportive Care in Cancer.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Hamadani, M. Norkin, W. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Weisdorf, N. Majhail, L. Burns, 2009, Bone Marrow Transplantation.

Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation.

P. Hari, D. Vesole, C. Bredeson, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Weisdorf, N. Majhail, L. Burns, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting

R. Vogel, D. Weisdorf, V. Bachanova, 2012, British journal of haematology.

Hematopoietic cell transplantation for mantle cell lymphoma: predictive value of pretransplant positron emission tomography/computed tomography and bone marrow evaluations for outcomes.

M. Linden, V. Bachanova, L. Burns, 2014, Clinical lymphoma, myeloma & leukemia.

Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of high‐dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma

Jeffrey S. Miller, D. Weisdorf, M. Arora, 2006, American journal of hematology.

Late effects after autologous hematopoietic cell transplantation.

L. Burns, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative.

A. Bracey, C. Anasetti, R. Champlin, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

M. Aljurf, J. Szer, J. Wingard, 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

M. Norkin, M. Perales, M. Horowitz, 2020 .

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis.

W. Wood, M. Aljurf, H. Lazarus, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Radiotherapy of CD45-expressing Daudi tumors in nude mice with yttrium-90-labeled, PEGylated anti-CD45 antibody.

M. Brechbiel, D. Vallera, L. Burns, 2007, Cancer biotherapy & radiopharmaceuticals.

Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.

W. Wood, M. Aljurf, M. Horowitz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipients.

R. Vogel, M. Solh, N. Majhail, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The effect of smoking on allogeneic transplant outcomes.

K. Ballen, O. Ringdén, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma.

D. Weisdorf, V. Bachanova, J. Lamba, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stratification of Allogeneic Hematopoietic Cell Transplant Patients by Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Stephanie J. Lee, A. Artz, A. Loren, 2017 .

Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients

D. Weisdorf, M. Arora, V. Bachanova, 2014, American journal of hematology.

Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers

C. Ustun, L. Mau, E. Denzen, 2019, Journal of Cancer Education.

A Phase 2 Trial of KIR Mismatched Unrelated Donor Transplantation Using In Vivo T-cell Depletion with ATG in AML: Children's Oncology Group AAML05P1 Study.

S. Meshinchi, T. Alonzo, R. Gerbing, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis.

W. Wood, M. Aljurf, H. Lazarus, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment.

D. Weisdorf, A. Bracey, C. Anasetti, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

W. Wood, Bryce Waldman, Z. DeFilipp, 2023, Blood reviews.

Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians

L. Burns, 2015 .

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).

J. Wagner, Priya Kumar, Jeffrey S. Miller, 2005 .

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.

J. Armitage, J. Vose, M. Horowitz, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients

W. Wood, A. El-Jawahri, T. Leblanc, 2021, Blood advances.

Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2015 .

Barriers to Access to Hematopoietic Cell Transplantation among Patients with Acute Myeloid Leukemia in Virginia.

R. Balkrishnan, K. Ballen, S. Devine, 2021, Transplantation and cellular therapy.

Umbilical Cord Blood Transplant after Reduced Intensity Conditioning Provides Outcomes Comparable HLA-Matched Siblings for Patients with High Risk and Advanced Acute Myeloid Leukemia.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006 .

Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

M. Aljurf, R. Gale, N. Callander, 2019, Bone Marrow Transplantation.

A Real-World Evidence Comparison of 1-Year Overall Survival and Relapse-Free Survival between Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Versus Antithymocyte Globulin or Post-Transplant Cyclophosphamide Following Allogeneic Hematopoietic Cell Transpl

M. Pasquini, Michael T. Hemmer, L. Kean, 2022, Blood.

Breaking the Age Barrier: Physicians' Perceptions on Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.

W. Wood, M. Sorror, D. Howard, 2021, Transplantation and cellular therapy.

Harvesting Hematopoietic Progenitors : “ Please Release Me , Let Me Go ”

K. Ballen, P. McCarthy, P. Mcsweeney, 2022 .

M. Aljurf, J. Szer, J. Wingard, 2012, Revista brasileira de hematologia e hemoterapia.

M. Aljurf, J. Szer, J. Wingard, 2012, Bone Marrow Transplantation.

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2008 .

New classification of chronic GVHD: added clarity from the consensus diagnoses

J. Witte, M. MacMillan, D. Weisdorf, 2009, Bone Marrow Transplantation.

Patient-centered care coordination in hematopoietic cell transplantation.

N. Majhail, N. Khera, C. Lemaistre, 2017, Blood advances.

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

M. Pasquini, M. Horowitz, Stephanie J. Lee, 2016 .

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.

D. Weisdorf, V. Bachanova, L. Burns, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers

C. Ustun, L. Mau, L. Burns, 2019, Journal of Cancer Education.

A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease.

T. Braun, S. Farag, S. Devine, 2023, Blood.

Challenges in Measuring Benefit of Clinical Research Training Programs—the ASH Clinical Research Training Institute Example

M. Crowther, L. Sung, S. Gitlin, 2015, Journal of Cancer Education.

M. Aljurf, J. Szer, J. Wingard, 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Clinical Research: Supportive CareFluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2016 .